CN Patent

CN105384694A — 一种取代的氨基嘧啶衍生物及其制备方法和药物用途

Assigned to Sichuan Haisco Pharmaceutical Co Ltd · Expires 2016-03-09 · 10y expired

What this patent protects

本发明涉及一种通式(I)和(II)所述的取代的氨基嘧啶衍生物及其光学异构体、药学上可接受的盐或共晶，以及制备方法和在制备肿瘤药物中的用途，其中通式(I)和(II)化合物为：，其中各取代基的定义与说明书的定义相同。

USPTO Abstract

本发明涉及一种通式(I)和(II)所述的取代的氨基嘧啶衍生物及其光学异构体、药学上可接受的盐或共晶，以及制备方法和在制备肿瘤药物中的用途，其中通式(I)和(II)化合物为：，其中各取代基的定义与说明书的定义相同。

Drugs covered by this patent

Patent Metadata

Patent number: CN105384694A
Jurisdiction: CN
Classification: —
Expires: 2016-03-09
Drug substance claim: No
Drug product claim: No
Assignee: Sichuan Haisco Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.